On Tuesday (October 30) the Canadian Marketing Agency (CMA) issued guidance for marketing in the cannabis industry following confusion and a warning from the federal government earlier in the month. 

Due to the implementation of the Cannabis Act on October 17, cannabis companies faced a nebulous time of regulation enforcement in terms of marketing and advertising in the country after the bill was passed in June.


The agency published a report titled CMA Guide on Permitted Cannabis Marketing Activities to help aid companies struggling with the restrictions from Health Canada.

“The guide reviews marketing practices that are permitted by new federal legislation, those that are prohibited, and those where caution should be exercised because the legislation is unclear,” CMA said in the announcement.

The agency confirmed this guideline will be updated as necessary to reflect new regulations.

Cannabis producers fail to comply following legalization

According to a report from BNN Bloomberg, Health Canada issued a warning notice to seven cannabis producers for falling outside the law promoting cannabis.

A spokesperson for the government agency said Health Canada had warned the companies of their activities and received confirmation the parties were targeting the error.

The government wouldn’t reveal which companies failed to comply with the regulations.

“In fairness to the [producers], there was no way to unpack the compliance of specific activities but to try them and see what happens,” Rebecca Brown, founder of Crowns Agency, told BNN Bloomberg.

While the timing matches with the warnings from Health Canada, it’s unclear whether the report from CMA was done in direct response to the errors from cannabis companies.

“A fair bit of confusion exists, not only for cannabis companies, but also for suppliers to the industry, from billboards and packaging to the sale of non-cannabis items such as promotional items,” Chris Bolivar, vice president of brand and marketing for cannabis retailer Fire and Flower, said.

In its report, CMA highlights one aspect which cannabis companies have thrived on: social media. Cannabis companies and personalities have raised their profiles through successful engagement through these platforms.

CMA explains there needs to be more clarification as to the rules when it comes to social media:

It is unclear whether the convention of a description on a social media page only requesting followers that are adults is a “reasonable step” to ensure the promotion cannot be accessed by a minor. If reasonable steps are taken, then Brand Elements, Informational Promotion and Brand Preference Promotion is allowable. If “reasonable steps” are not taken, then the promotion must be limited to a Brand Element and not associate with a way of life or young persons.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE:ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws

Keep reading... Show less

TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced Jason Ackerman Chief Executive Officer and Executive Chairman of TerrAscend, Keith Stauffer Chief Financial Officer, and Jason Wild Chairman, will participate in three upcoming conferences:

  • Cowen’s 3rd Annual Boston Cannabis Conference, a virtual event taking place November 30-December 2 , 2020. Jason Ackerman will participate in a panel, U.S. MSOs: The West, on November 30, 2020 at 10:25 a.m. ET . Management will also host one-on-one meetings with investors throughout the conference.
  • 2020 Cantor Fitzgerald Virtual Cannabis MSO Summit, a virtual event taking place on December 15-16, 2020 . Jason Ackerman is scheduled to participate in a fireside chat on December 16 th at 1:00 p.m. ET . To register for the fireside chat: Click Here
  • 23 rd Annual Needham Virtual Growth Conference, a virtual event taking place January 11-15, 2021 . Jason Ackerman is scheduled to participate in a fireside chat on January 14, 2021 at 2:45 p.m. ET . Management will also host one-on-one meetings with investors throughout the conference. To register for the fireside chat: Click Here

The Canadian Securities Exchange (“CSE”) has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Keep reading... Show less
  • Aurora strategically positioned within two of the largest legal cannabis markets outside of Canada
  • Agreement with Israeli leader Cantek provides access to Israel’s drugstore channel
  • Finished product is co-branded under Aurora and Cantek brands

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today it has entered into a strategic Supply Agreement (the “Agreement”) with Cantek Holdings (“Cantek”), one of Israel’s leaders in the medical cannabis field.

Keep reading... Show less